SCHEMBL10051004

SCHEMBL10051004

B[C@@H]1O[C@H](COC)C(OP(C)(=O)O)[C@@H]1O

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 1/20 0.34
▸ SMPD1 P17405 2/20 0.33
▸ AMDHD2 Q9Y303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10005831 1.00 FBP1 (0.34) FBP1SMPD1AMDHD2
SCHEMBL21202641 1.00 FBP1 (0.34) FBP1SMPD1AMDHD2
SCHEMBL16996706 0.92 FBP1 (0.36) FBP1AMDHD2
SCHEMBL13172425 0.92 FBP1 (0.36) FBP1AMDHD2
SCHEMBL12523685 0.89 SMPD1 (0.41) SMPD1
SCHEMBL15964500 0.88 SMPD1 (0.31) FBP1SMPD1
SCHEMBL17209504 0.88 — —
SCHEMBL17208119 0.88 — —
SCHEMBL21202645 0.87 SMPD1 (0.30) FBP1SMPD1
SCHEMBL21474777 0.87 SMPD1 (0.30) FBP1SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702652-B2 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION A/S (DK) 2023-07-18 — — US disclosed
US-20230183283-A1 NOVEL GLYCOSIDE COMPOUND AND PRODUCTION METHOD THEREFOR BONAC CORPORATION (JP) 2023-06-15 — — US disclosed
US-9885035-B2 Method for the synthesis of a bifunctional complex NUEVOLUTION A/S (DK) 2018-02-06 — — US disclosed
US-20170247688-A1 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES NUEVOLUTION A/S (DK) 2017-08-31 — — US disclosed
US-9574189-B2 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION A/S (DK) 2017-02-21 — — US disclosed
US-20170009225-A1 METHOD FOR THE SYNTHESIS OF A BIFUNCTIONAL COMPLEX NUEVOLUTION A/S (DK) 2017-01-12 — — US disclosed
US-9487775-B2 Method for the synthesis of a bifunctional complex NUEVOLUTION A/S (DK) 2016-11-08 — — US disclosed
US-20160083720-A1 METHOD FOR THE SYNTHESIS OF A BIFUNCTIONAL COMPLEX NUEVOLUTION A/S (DK) 2016-03-24 — — US disclosed
US-9284600-B2 Method for the synthesis of a bifunctional complex Neuvolution A/S (DK) 2016-03-15 — — US disclosed
US-9109248-B2 Method for the synthesis of a bifunctional complex NUEVOLUTION A/S (DK) 2015-08-18 — — US disclosed
US-8808984-B2 Method for synthesising templated molecules Neuvolution A/S (DK) 2014-08-19 — — US disclosed
US-20130040823-A1 METHOD FOR THE SYNTHESIS OF A BIFUNCTIONAL COMPLEX NUEVOLUTION A/S (DK) 2013-02-14 — — US disclosed
US-8206901-B2 Method for the synthesis of a bifunctional complex NUEVOLUTION A/S (DK) 2012-06-26 — — US disclosed
US-7915201-B2 Ligational encoding of small molecules NUEVOLUTION A/S (DK) 2011-03-29 — — US disclosed
US-20100286290-A1 ENZYME ACTIVITY ASSAY USING ROLLING CIRCLE AMPLIFICATION IN SITU RCP A/S (DK) 2010-11-11 — — US disclosed
US-20090264300-A1 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES NUEVOLUTION A/S (DK) 2009-10-22 — — US disclosed
US-20090239211-A1 Method For Enrichment Involving Elimination By Mismatch Hybridisation NUEVOLUTION A/S (DK) 2009-09-24 — — US disclosed
US-20090143232-A1 METHOD FOR SYNTHESISING TEMPLATED MOLECULES NUEVOLUTION A/S (DK) 2009-06-04 — — US disclosed
US-7413854-B2 Method for synthesising templated molecules NUEVOLUTION A/S (DK) 2008-08-19 — — US disclosed
US-20070026397-A1 Method for producing second-generation library NUEVOLUTION A/S (DK) 2007-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183283-A1 NOVEL GLYCOSIDE COMPOUND AND PRODUCTION METHOD THEREFOR SLC5A11, POLRMT, MAPK11 FBP1 383/4885SMPD1 3862/4885AMDHD2 1249/4885
US-20090264300-A1 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES RNGTT, DUT, EMG1 FBP1 934/4885SMPD1 2283/4885AMDHD2 1579/4885
US-20090143232-A1 METHOD FOR SYNTHESISING TEMPLATED MOLECULES FGB, ILK, TBCB FBP1 3804/4885SMPD1 2923/4885AMDHD2 2822/4885
US-20100286290-A1 ENZYME ACTIVITY ASSAY USING ROLLING CIRCLE AMPLIFICATION RNASE1, RNGTT, DNASE1 FBP1 598/4885SMPD1 168/4885AMDHD2 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback